Антимикробная терапия при муковисцидозе у детей

1. Капранов Н.И., Каширская И.Ю. и др. Современные достижения и актуальные вопросы в проблеме муковисцидоза / / Вестн. Рос. АМН.— 1992.— No 4.— С 34—39.

2. Рожавин М.А. Причины несовпадения лабораторных и клинических данных о чувствительности Гр-бактерий к антибиотикам / / Антибиотики. 1988.— No 6.— С.460—463.

3. Фейджельсон Ж. Муковисцидоз (опыт наблюдения за 222 больными за 38 лет педиатрической практики) / / Педиатрия.— - 1992,— No 3 — С.56—61.

4. Andersen D.H. Cystic fibrosis of pancreas and its relation to celiac disease: clinical and pathological study / / Am. J. Dis. Child.— 1938.— Vol.56.— P.344—399.

5. Baker N.R. / / Pseudomonas Infection and Alginates: Biochemistry, Genetics and Pathology.— London: Chapman and Hall, 1990.—P.95—108.

6. Baltimore K.S., Christie C.D.C., Walker Smith G.J. Immunohistopothologic localization of P. aerug. in lungs from patients with CF / / Am. Rev. Respir. Dis.— 1989.— V ol.140.— P .1650—1661.

7. Le Bell M. Fluoroqunolones in the -treatment of CF: a critical appraisel / / Eur. J. Clin. Microbiol. Infect. Dis.— 1991.— Vol.10.— P.313—314.

8. Bergan Т., Hoiby N. Epidemiological markers for P. aeruginosa / / A cta Pathol. P .553—560.

9. Daviol T. et al. / / Cystic Fibrosis News.— 1989.— Vol.4.— P.8—9.

10. Doring G., Hoiby N. Immunological aspects of CF / / Chest.— 1988.— Vol.94, No 2.— Suppl.— P. 109—114.

11. Duncan M., Geddes M.D. Antimicrobial therapy against st. aureus. P. aeruginosa and P. cepacia / / Ibid.— P. 140—144.

12. Friend P.A. Pulmonary infection in CF / / J. Infect.— 1986.— Vol.13.— P.55—72.

13. Gilligan P.H. Microbiology of airway disease in patientwith CF / / Clin. Microbiol. Rev.— 1991.— Vol.4.— P .35—51.

14. Goodchild M.C., Dodge G.A. / / Cystic Fibrosis: Manual of Diagnosis and Management. 2-nd Ed.— London, 1989.— P.53—70.

15. Hodson M.E. Cystic fibrosis / / Postgrad Med. J.— 1984.— Vol.60,— P.225—233.

16. Hodson M.E. Antibiotic treatment aerosol therapy / / Chest- 1988.— Vol.94, No 2.— Suppl.— P.156—160.

17. Hoiby N., Friis B. et al. Antimicrobial chemotherapy in CF patients / / Acta Paediatr. Scand.— 1982.— Suppl.301.— P.75— 100.

18. Hoiby N., Doring G., Schiotz P.O. / / Annu. Rev. Microbiol.— 1986,— Vol.40.— P.29—53.

19. Hoiby N. Hemophilus influenzae, staphilococcus aureus, P.cepacia, P.aeruginosa in patients with CF / / Chest.— 1988.— Vol.94, No 2,— Suppl.— P.97—102.

20. Hoiby N., Pedersen S.S. / / Acta Paediatr. Scand.— 1989.— Vol.78.— P.395—404.

21. Hoiby N., Koch C. / / Thorax.— 1990.— Vol.45.— P.881—884.

22. Hoiby N., Doring G., Schiotz P.O. Pathogenic mechanisms of chronic P. aeruginosa infection in CF patients / / Antibiot. Chemother.— 1987.— Vol.39.— P.69—76.

23. Hutabarat R.M., Unadkat J.D. et al. Pharmakokinetics and drug disposition / / Clin. Pharmacol. Ther.— 1991.— Vol.49.— P.402—409.

24. Isles A., Maclusky I. et al. P. cepacia Infection in CF / / J. Pediatr.— 1984.— Vol.104.— P.206—210.

25. International CF Assosiation News Letter.— 1989.— Vol.245, No 20.— P. 1073—1080.

26. Jacobs R.F., Trang J.M. et al. Ticarcillin/clavulanic acid pharmacokinetics in children and youilg adults with CF / / J. Pediatr.— 1985.— Vol.106.— P. 1001—1007.

27. Jensen T. et al. / / Eur. J. Clin. Microbiol.— 1987.— Vol.6.— P .618—622.

28. Jensen T., Pedersen S.S. et al. / / Antibiot. Chemother.— 1989.— Vol.42.— P .237—246.

29. Kelly N.M., Fitzgerald M.X. et al. Does Pseudomonas crossinfection occur between CF patients / / Lancet.— 1982.— Vol.2.— P .688—690.

30. Kerem E., Grey M. et al. / / J. Pediatr.— 1990.— Vol.116.

31. Kharazmi A., Hoiby N. et al. P.aerug. exoproteases inhibit human neutrophil chemiluminescence / / Infect. Immun.— 1984.— Vol.44.— P.587—591.

32. Koch C., Pedersen S.S., Hoiby N. Treatment of chronic P.aerug infection in CF. Effects and side-effects of antibiotics / / European Working Group for Cystic Fibrosis. Annual Meeting, 17-th. Proceedings.— Copenhagen, 1991.— P. 147— 156.

33. Me Laughlin F., Mattens W.G. et al. Clinical and bacteriological responses to three antibiotics regimens for acute exacerbation of CF: ticarcillin — tobramycin, aclocillin — tobramycin and aclozillin — placebo / / J. Infect. Dis.— 1983.— Vol. 147.— P .559—567

34. LeederJ.S., Spino M. et al. Ceftazidime disposition in acute and stable CF / / Clin. Pharmacol. Ther.— 1984.— Vol.36.— P.355—362.

35. Levy J., Smith A.L. et al. Bioactivity of gentamicin in purulent sputum from patients with CF or bronchoectasis: comparison with activity in serum / / J. Infect. Dis.— 1983.— Vol. 148.— P. 1069.

36. Levy J. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy / / Chest.— 1988.— Vol.94, No 2.—Suppl.— P.150—154.

37. Littlewood J.M .,-M iller M.G., Chonein A.T. / / Lancet.— 1985.— Vol.2.— P .865.

38. Michel B.C. A ntibacterial literature published between 1980 and February 1987 / / Chest.— therapy in cystic fibrosis. A rewiew of 1988.— Vol.94, No 2,— Suppl.— P .129—140.

39. Moller N.E., Hoiby N. / / Scand J. Infect. Dis.— 1981.— Suppl. 24.— P .87—91.

40. Ong E.L.C. et al. / / Thorax.— 1989.— Vol.44— P.739—742.

41. Pedersen S.S., Jensen T. et al. / / Acta Paediatr. Scand.— 1986,— Vol.75.— P .840—845.

42. Pedersen M., Stowring S. et al. Comparative study of amoxycillin in persistent H.infection of the lower respiratory tract in children with chronic lung disease / / Scand. J. Infect. Dis.— 1986.— Vol. 18.— P .245—254.

43. Pedersen B.K., Kharazmi A. et al. Selective modulation of the CD4 molecular complex by P. aerug. alkaline protease and elastase / / Scand. J. Immunol.— 1987.— Vol.26.— P.91—94.

44. Pedersen B.K., Kharazmi A. Inhibition of human killer cells activity by P. aerug. alkaline protease and elastase / / Infect. Immun.— 1987.— Vol.55.— P.986—989.

45. Pedersen S.S., Jensen T. et al. Management of P. aerug. lung infection in Danish CF patients / / Acta Paediatr. Scand.— 1987.— Vol.76.— P .955—961.

46. Pedersen S.S., Koch C., Hoiby N. Prevention and early treatm ent of P. aerug. infection in CF basic and clinical research / / European Working Group for Cystic Fibrosis, Annual Meeting, 17-th: Proceedings.— Copenhagen, 1991.— P. 135—144.

47. Pedersen S.S., Hoiby N. et al. / / Thorax.— 1992.— Vol.47.— P.6—13.

48. Petersen N.T., Hoiby N. et al. / / Acta Paediatr. Scand.— 1981.— Vol.70.— P .623—628.

49. Pitchford K.C., Corey M. et al. Pseudomones species contamination of CF patients home inhalated equipment / / J. Pediatr.— 1987.— Vol.111.— P .212—216.

50. Pressler Т., Szaff М., Hoiby N. / / Acta Paediatr. Scand.— 1984.— Vol.73.— P .541—547.

51. Prince A.S., Nei H.C.- Brief Clinical and laboratory observations: use of piperacillin, a sem isynthetic penicilin, in the therapy of acute exacerbation of pulmonologic disease in patients with CF / / J. Pediatr.— 1980.— Vol.97.— P. 146—151.

52. Rampol R. et al. / / Infect. Immun.— 1980.— Vol.27.— P.614—619

53. Shapera R.M., Warwick W.J., Matsen J.M. Clindamycin therapy of staphylococcal pulmonary infection in patients with CF / / J. Pediatr.— 1981.— Vol.99.— P .647—650.

54. Shwab U., Frank F. et al. / / European Cystic Fibrosis Conference, 17-th.— Copenhagen, 1991.— Abstr. 75.

55. Schlesinger E., Miller Ml. et al. Effect of longterm continuous anti-staphylococcal antibiotic treatment in young children with CF / / Cystic Fibrosis Horizons / Ed. D. Lawson.— New York, 1984.— P.280-414.

56. Smith L., Ramsey B. Antibiotic therapy for patients with CF / / Cystic Fibrosis Symposium.— The Ritz — Carlton, Atlanta, 1991.— P.50.

57. Spino S.M., Chai R.P. et al. CloXacillin absorbtion and disposition in CF / / J. Pediatr.— 1984.— Vol. 105.— P.823—835.

58. Strandvick B. Antibiotic therapy of pulmonary infection in Cf; Dosage schedules and duration of treatment / / Chest.— 1988.— Vol.94, No 2.— Suppl.— P. 146—149.

59. Szaff М., Hoiby N. Antimicrobial treatment of St. aureus in CF / / Acta Paediatr. Scand.— 1982,— Vol.71.— P .821— 826.

60. Szaff М., Hoiby N., Flensborg E.W. / / Ibid.— 1983.— Vol.72.— P .651—657.

61. Thomassen M.J., Demko C.A., Doershuk C.F. CF: a review of pulmonary infections / / Pediatr. Pulmonol.— 1987.— Vol.3.— P .334-351.

62. Valerius N.H., Koch C., Hoiby N. / / Lancet.— 1991.— Vol.338.— P .725—726.

63. Wall M.A., Terry G. et al. Inhaled antibiotics in CF / / Ibid.— 1983.— Vol.l.— P .1325.

64. Wood D.E. et al. / / Infect. Immun.— 1980.— Vol.30.— P .694—699.

65. Woolf R.A., Koup J.R. et al. Pharmacokinetics of high dose aolocillin sodium in patients with CF / / Clin. Pharmacol.— 1985.— Vol.4.— P.664—669.